Drug delivery

Simple solvent-free heating method for making siRNA-delivery nanoparticles as an alternative to microfluidics

Updated

Abstract

siRNA- were formulated with particle sizes of 104.2 ± 34.7 nm and an encapsulation efficiency of 83.3 ± 4.1%.

  • A new may efficiently produce nucleic acid-ionizable LNPs without the need for organic solvents.
  • Optimization of process parameters is necessary for precisely sized particles and effective nucleic acid encapsulation.
  • Thermocycling siRNA-ionizable LNPs exhibited comparable morphological structures to those produced by commercial microfluidics ionizable LNPs.
  • These thermocycling LNPs demonstrated a longer shelf life at 4°C compared to microfluidics-derived counterparts.
  • The proposed method could address challenges such as high production costs and stability issues associated with traditional microfluidic technology.

Simplified

Key numbers

104.2 ± 34.7 nm
Particle Size
Size of thermocycling siRNA-.
83.3 ± 4.1%
Encapsulation Efficiency
Efficiency of siRNA encapsulation in thermocycling LNPs.
3 months
Shelf Life
Shelf life of thermocycling siRNA- at 4°C.

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

No potential conflict of interest was reported by the authors.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free